dc.contributor.author |
Tadamun H Adbullah |
|
dc.contributor.author |
Ismail I Latif |
|
dc.contributor.author |
Khudair Kh Ibrahim |
|
dc.date.accessioned |
2023-10-21T07:13:28Z |
|
dc.date.available |
2023-10-21T07:13:28Z |
|
dc.date.issued |
2020-10 |
|
dc.identifier.citation |
https://doi.org/10.26505/DJM.19015031015 |
en_US |
dc.identifier.issn |
Print ISSN 2219-9764 |
|
dc.identifier.issn |
Online ISSN 2617-8982 |
|
dc.identifier.uri |
https://djm.uodiyala.edu.iq/index.php/djm |
|
dc.identifier.uri |
http://148.72.244.84:8080/xmlui/handle/xmlui/5574 |
|
dc.description.abstract |
Background: Psoriasis is a multifactorial and inflammatory skin disease. The etiology is not well. A large number of cytokines have been shown to be elevated in serum concentration and psoriatic lesion, and the elevation is correlate with psoriasis severity.
Objective: To evaluate TNF-a and TGF-B1 index in psoriasis which could help as predictive marker of severity of psoriasis in Baquba teaching hospital Iraq.
Patients and Methods: Forty nine patients with psoriasis (27male and 22 female) were included in this study . Their age range between (7-70) years old. The study was performed in Baquba Teaching Hospital during period from December 2018 to June 2019. Each case was diagnosed by Dermatologist.
Results: In our study we compare the mean, standard deviation and P. value of TNF-a and TGF-B in patients of psoriasis. We have found that psoriasis patients have a highly significant difference compared to controls(P=0.001) in both genders.
Conclusion: This study concludes a significant association between tumor necrosis factor alpha and transforming growth factor beta-1 in psoriasis patients in both gender. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
University of Diyala - College of Medicine |
en_US |
dc.relation.ispartofseries |
Vol 19;Issue 1 |
|
dc.subject |
Psoriasis |
en_US |
dc.subject |
Tumor necrosis factor alpha |
en_US |
dc.title |
Role of Tumor Necrosis Factor Alpha and Transforming Growth Factor Beta as Predictive Marker for Psoriasis Patients |
en_US |
dc.type |
Article |
en_US |